Malignancy
Conditions
Interventions
Sponsors
Kobe University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with age: <= 20 years 2.Patient will provide written informed consent and authorization to release personal health information. 3.Inpatients.
Exclusion criteria
Exclusion criteria: 1.No known CNS metastasis. 2.Impairment of GI function or GI disease 3.Other concurrent severe and/or uncontrolled concomitant medical conditions 4.Impaired cardiac function or clinically significant heart disease, including any one of the following: _Angina pectoris within 3 months _Acute myocardial infarction within 3 months _Other clinically significant heart disease 5.No exist the aspirin-induced asthma. 6.No known hypersensitivity to any component of study regimen. 7.No use of zidovudine 8.Drug dependence disease and alcoholism 9.Patients unwilling or unable to comply with the protocol 10.No use of aspirin 11.Under the pregnancy or the nursing 12.Women of child-bearing potential who are pregnant. 13.No participate in other clinical trials. 14.Without participating in a similar examination clinical trial 15.Patients judged inappropriate for this study by physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety: Adverse events and serious adverse drug reactions, abnormal changes in hematology and chemistry lab values, specifically those associated with hepatic and renal function; and assessment of physical examinations, vital signs | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.pain score 2.Improvement level of feeding, taking medicine, drinking water, conversation, and sleep | — |
Countries
Japan
Contacts
Public ContactTakeshi Ioroi
Kobe University Hospital Department of Hospital Pharmacy
Outcome results
None listed